HealthcareReportTrends

High Potency APIs Market High potency APIs facilitate precision and targeted therapy approach. Thus, the rising prevalence of chronic and old age diseases have intensified the demand for HPAPIs. The high potency APIs market will rake USD 49.1 billion in revenues while expanding with an 9% CAGR in the 2023-2032. The rapid expansion of cancer patient pool is forecasted to accelerate the revenue creation for the market players globally. According to ‘Our World in Data’, 8.9 million people are estimated to have succumbed to cancer in 2016. Investments are expected to flow towards drug development which is likely to augment the global market through the review period. The competitive landscape of the market is highly lucrative and rising investments is prognosticated to boost the manufacturing of HPAPIs. Furthermore, the key players are anticipated to strategize agreements, acquisitions, and partnerships for gaining edge over competitors. The developments witnessed in the healthcar...

Myasthenia Gravis Disease Market The surging cases of neuromuscular disorders are estimated to favor the market growth globally. Myasthenia gravis is referred to as a neuromuscular disorder which results in the skeletal muscles to weaken. The Myasthenia Gravis Disease Market is projected to reach USD 1.97 billion by 2032 at 7.9% CAGR during the forecast period 2023-2032. The disease generally occurs due to the impairment of communication between the nerve cells and the muscles and causes difficulty in the relaxation and contraction of muscles. The antibodies present in the body destroy the receptor for acetylcholine at the neuromuscular joint which prevents the muscles from contracting and performing its normal function. Major Key Players: Leading Myasthenia Gravis Disease Market Players are Fresenius Kabi, GSK plc, AbbVie Inc., Biogen Inc., Bristol-Myers Squibb Co., F. Hoffman-La Roche Ltd., Cipla, RPG Life Sciences, Teva Pharmaceutical Industries Ltd., Apotex Corporation,...

Menopause Treatment Market Menopause causes uncomfortable symptoms, such as hot flashes, vaginal dryness, and weight gain and menopause treatments such as hormonal and non-hormonal treatments help to relieve these symptoms. Over the years, major market players in the menopause treatment are focusing on various growth strategies such as product launches, product advancements and expansions to cater to the growing needs for patients seeking treatment for menopause symptoms. Global Menopause Treatment Market  is expected to have a market value of  USD 17.3 Billion by 2032 at 6.10% CAGR during the forecast period. For instance, in April 2019, Otsuka Pharmaceutical launched EQUELLE, a non-prescription, non-hormonal supplement to alleviate the frequency of hot flashes and muscle aches associated with menopause in the US. Such strategies push the demand for branded as well as generic menopausal drugs, thus promising huge growth for the industry. Major Key Players: ...

Pharmaceutical Excipients Market Pharmaceuticals are important components of a formulation that offers effective drug absorption. Excipients must comply with the regulatory requirements and must suit the intended dosage form. The compatibility is crucial in dosage forms that incorporate coating, controlled and sustained release, oil base (emulsifiers), and taste masking. The Pharmaceutical Excipients Market will witness a CAGR of 7.89 %, along with a value of USD 9.35 billion by 2030 in the forecast period. Excipients used in the manufacturing of drug serve as binders, disintegrants, glidants, or diluents. Therefore, multifunctional excipients can reduce the manufacturing cost and drug development of the product. Drivers and Restraints Owing to the patent expiries, the market has witnessed a robust growth rate in the recent times. Moreover, with the large patient population base and growing demand for pharmaceutical products will propel the growth of the market globally. ...

Veterinary Medicine Market Veterinary medicine can be defined as medicines for prevention, diagnosis, and treatment of animals to cure them of wounds or any disorder. The Veterinary Medicine Market is expected to reach USD 44.92 billion at CAGR of 5.6% during the forecast period of 2023 to 2032 . Market Research Future (MRFR), in their latest report on the same, discussed the impact that the market can witness in coming years. Factors like growing adoption rate of pets, better medicines to treat, hike in investment to buy pets, increasing availability of medicines, government initiatives for domesticated animals, high integration of drug therapies, and others are expected to play crucial role for the global veterinary medicine market. Major Key Players: MRFR recognizes Veterinary Medicine Market Players are — Boehringer Ingelheim, Ceva, Chanelle Pharma Group, Dechra Pharmaceuticals plc, Elanco, Merck Animal Health, Norbrook Laboratories, Vetoquinol S.A., Bayer AG, a...

Body Contouring Devices and Procedures Market Body contouring devices and procedures market is expected to reach USD 1586.89 Million by 2030 at 14.1% CAGR during the forecast period 2022-2030. Due to increasing prevalence of obesity across the globe many of the companies are in the race to introduce better treatment for obesity. Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market. Additionally, the growing research and development expenditure by the government as well as private sector is likely to contribute to the market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. However, the high cost of surgery with advanced technologies may hamper the market growth during the assessment period. Major Key Players: Some of the Key Body Contouring Devices and Pr...

Medical Radiation Detection, Monitoring & Safety Market The global  medical radiation detection, monitoring & safety market   is expected to grow at a CAGR of 7% during the forecast period. Radiation Detection, Monitoring & Safety products provides safety environment in healthcare settings. The growing prevalence of cancer has led to growing use of radioactive materials for the treatment of cancer. Radiotherapy has emerged as one of the most promising treatment avenues for cancer, leading to growing use of radioactive substances in the oncology sector. This is likely to remain one of the most important drivers for the global medical radiation detection, monitoring, and safety market over the forecast period, as cancer has become a major problem for the healthcare sector in modern times and is likely to remain one of the key challenges facing the healthcare sector in the coming years. Increasing awareness about radiation safety among workers is also likely ...